findmyKOL

Maria Devita, MD

Basic profile

Lenox Hill Hospital

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Maria Devita is a Nephrology physician affiliated with Lenox Hill Hospital. OpenAlex indexes 70 publications with 1,632 citations (h-index 20); ClinicalTrials.gov lists 3 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
70publications

Distinct works indexed by OpenAlex.

1,632citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

6 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    71.7%
    Calcium channel blocker13.8%
    Amlodipine Besylate69%Nifedipine Er32%
    Part D29 patients
    Statin13%
    Atorvastatin Calcium42%Rosuvastatin Calcium36%Simvastatin23%
    Part D<11 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    15.9%
    SGLT2 inhibitor6.5%
    Farxiga100%
    Part D15 patients
    Metabolic Alkalinizer6.2%
    Potassium Citrate Er100%
    Part D<11 patients

    + 1 more class in this area

  • Musculoskeletal

    5.4%
    Xanthine oxidase inhibitor5.4%
    Allopurinol100%
    Part D11 patients
Where care is delivered (Part B)29.3% facility · 70.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”